OverT Bio Receives 120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements
| IBSAX Fund | USD 20.88 0.19 0.90% |
Slightly above 61% of Vy Baron's investor base is looking to short. The analysis of overall sentiment of trading Vy Baron Growth mutual fund suggests that many investors are alarmed at this time. Vy Baron's investing sentiment can be driven by a variety of factors including economic data, Vy Baron's earnings reports, geopolitical events, and overall market trends.
IBSAX |
OverT Bio, an NYC-based cell therapy company, today announced that it has been awarded a 120,000 G-Rex Grant from ScaleReadyTM, in collaboration with
Read at businesswire.com
 |
Vy Baron Fundamental Analysis
We analyze Vy Baron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vy Baron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vy Baron based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Vy Baron is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Vy Baron Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vy Baron mutual fund to make a market-neutral strategy. Peer analysis of Vy Baron could also be used in its relative valuation, which is a method of valuing Vy Baron by comparing valuation metrics with similar companies.
Peers
Vy Baron Related Equities
| IMCDX | Voya Emerging | 0.00 |
| ||
| ILMBX | Voya Limited | 0.10 |
| ||
| ILBPX | Voya Limited | 0.11 |
| ||
| IMBAX | Voya Limited | 0.11 |
| ||
| ILBAX | Voya Bond | 0.33 |
| ||
| ILABX | Voya Bond | 0.44 |
| ||
| ILUAX | Voya Bond | 0.44 |
| ||
| IMCVX | Voya Multi | 0.51 |
| ||
| IMOPX | Voya Midcap | 0.76 |
|
Other Information on Investing in IBSAX Mutual Fund
Vy Baron financial ratios help investors to determine whether IBSAX Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IBSAX with respect to the benefits of owning Vy Baron security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |